Luca Grisetti

Subtype-dependent PD-L1 stability and immune context shape immunotherapy response in hepatocellular carcinoma

Luca Grisetti, Clarissa J. C. Garcia, Paola Tarchi, Claudio Tiribelli et autres

it (code pays fourni par la source)

The ncRNA-AURKA Interaction in Hepatocellular Carcinoma: Insights into Oncogenic Pathways, Therapeutic Opportunities, and Future Challenges

Clarissa Joy C. Garcia, Luca Grisetti, Claudio Tiribelli, Devis Pascut

it (code pays fourni par la source)

FRI-516-YI Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation

Luca Grisetti, Anna Alessia Saponaro, Caecilia Sukowati, Deborah Bonazza et autres

The role of Aurora kinase A in hepatocellular carcinoma: Unveiling the intriguing functions of a key but still underexplored factor in liver cancer

Luca Grisetti, Clarissa Joy C. Garcia, Anna Alessia Saponaro, Claudio Tiribelli et autres

it (code pays fourni par la source)

The expression of Aurora Kinase A and its potential role as a regulator of Programmed Death-Ligand 1 in hepatocellular carcinoma: Implications for immunotherapy and immune checkpoint regulation in hepatocarcinogenesis

Luca Grisetti, Anna Alessia Saponaro, Caecilia Sukowati, Paola Tarchi et autres

it, id (code pays fourni par la source)

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals

Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli et autres

it (code pays fourni par la source)

MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma

Luca Grisetti, Niệm Văn Thành Võ, Như Nhật Quỳnh Nguyễn, Lory Saveria Crocè et autres

it, vn (code pays fourni par la source)